HJURP and cancer: HJURP is considered an oncogene as its overexpression has been associated with cancers (Chen et al., 2018; Kang et al., 2020) including breast cancer (Coates et al., 2010; Hu et al., 2010; Montes de Oca et al., 2015), lung cancer (Kato et al., 2007), ovarian cancer (Dou et al., 2022), glioblastoma (Valente et al., 2013; Valente et al., 2009), hepatocellular carcinoma (Chen et al., 2018; Hu et al., 2017; Luo et al., 2022), colorectal cancer (Kang et al., 2020), and pancreatic cancer (Wang et al., 2020).